Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Shah Rajeev M.
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   49    
Direct Shares   20,000    

Indirect Shares

   279,677,593      
Direct Value   $137,300    

Indirect Value

   $1,854,304,495      
Total Shares   279,697,593      
Total Value   $1,854,441,795      


Kala Pharmaceuticals, Inc. $137,300 Kala Pharmaceuticals, Inc. $137,300
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    38   
    13    

     Stock price went up :
    19   
    8    
     Stock price went down :
    19   
    5    
   
     Gain/Loss Ratio :
   0.0   
   1.6   
     Percentage Gain/Loss :
   12.2%
 -60.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ra Pharmaceuticals, Inc. RARX Director, 10% Owner 2016-10-31 0 2020-04-02 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director, 10% Owner 2016-11-21 0 2017-10-12 1,441,070    Premium*  
            Kala Pharmaceuticals, Inc. KALA 10% Owner 2021-06-17 20,000 2022-05-26 7,039,613    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2022-12-02 109,661    Premium*  
            Eidos Therapeutics, Inc. EIDX Director 2018-06-22 0 2018-06-22 2,162,671    Premium*  
            Satsuma Pharmaceuticals, Inc. STSA Director, 10% Owner 2019-09-17 0 2023-06-06 0    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 10% Owner 0 2021-03-11 3,115,008    Premium*  
            89bio, Inc. ETNB Director, 10% Owner 2019-11-11 0 2024-04-11 14,175,398    Premium*  
            Synthorx, Inc. THOR 10% Owner 2020-01-23 0 2020-01-23 0    Premium*  
            Black Diamond Therapeutics, Inc. BDTX Director 2021-05-20 0 2023-07-05 3,525,754    Premium*  
            Scpharmaceuticals Inc. SCPH 10% Owner 2020-02-14 0 2021-03-15 2,727,446    Premium*  
            Verastem, Inc. VSTM 10% Owner 0 2020-06-25 16,142,051    Premium*  
            Enliven Therapeutics Ord Shs ELVN Former 10% owner 2020-03-16 0 2023-02-23 2,122,465    Premium*  
            TG Therapeutics Inc TGTX 10% Owner 0 2020-09-09 12,629,868    Premium*  
            Vaxcyte, Inc. PCVX 10% Owner 0 2020-10-08 5,001,593    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 2020-06-23 0 2022-10-14 0    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2020-06-25 0 2020-07-02 5,140,408    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2020-06-30 2,281,249    Premium*  
            Nkarta, Inc. NKTX Director, 10% Owner 2020-07-14 0 2024-03-27 10,805,129    Premium*  
            Pandion Therapeutics, Inc. PAND 10% Owner 2020-07-21 0 2020-07-21 1,770,023    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 2,003,653    Premium*  
            Iteos Therapeutics, Inc. ITOS Former 10% Owner 2020-07-28 0 2024-05-12 3,517,259    Premium*  
            Inhibrx, Inc. INBX 10% Owner 2020-08-21 0 2020-08-21 2,129,003    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 2,805,045    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP 10% Owner 2020-09-29 0 2020-09-29 1,710,265    Premium*  
            Cardiff Oncology Inc CRDF 10% Owner 0 2020-09-30 3,290,000    Premium*  
            Orchard Therapeutics Plc ORTX 10% Owner 2020-08-10 0 2020-09-24 9,880,865    Premium*  
            Viridian Therapeutics Ors Shs VRDN 10% Owner 0 2020-12-07 410,686    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2021-02-04 0 2021-02-04 11,651,597    Premium*  
            Vor Biopharma Inc. VOR Director, 10% Owner 2021-02-09 0 2022-12-09 22,748,880    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 2021-05-04 0 2023-01-06 6,144,881    Premium*  
            Aerovate Therapeutics, Inc. AVTE Director, 10% Owner 2021-07-02 0 2021-07-02 311,170    Premium*  
            Acumen Pharmaceuticals, Inc. ABOS Director, 10% Owner 2021-07-06 0 2023-07-21 14,932,063    Premium*  
            Cytek Biosciences, Inc. CTKB Director, 10% Owner 2021-07-27 0 2022-03-15 13,381,054    Premium*  
            Icosavax, Inc. ICVX Director, 10% Owner 2021-08-02 0 2024-02-19 0    Premium*  
            Eliem Therapeutics, Inc. ELYM Director, 10% Owner 0 2021-08-12 841,087    Premium*  
            Rxsight, Inc. RXST 10% Owner 0 2021-08-03 3,052,796    Premium*  
            Tyra Biosciences, Inc. TYRA Director, 10% Owner 2021-09-17 0 2024-02-06 10,416,609    Premium*  
            Dice Therapeutics, Inc. DICE Former 10% owners and ... 2021-09-17 0 2023-08-09 0    Premium*  
            An2 Therapeutics Ord Shs ANTX 10% Owner 2022-03-29 0 2023-08-18 5,551,295    Premium*  
            Pepgen Inc. PEPG Director, 10% Owner 2022-05-10 0 2024-02-09 10,689,545    Premium*  
            Wave Life Sciences Ltd. WVE Director, 10% Owner 2022-06-16 0 2023-12-11 18,202,009    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 0 2023-01-20 11,609,704    Premium*  
            Silverback Therapeutics, Inc. SBTX Director, 10% Owner 2022-11-08 0 2024-03-27 10,860,977    Premium*  
            Acrivon Therapeutics, Inc. ACRV Director, 10% Owner 2022-11-17 0 2024-04-11 8,340,508    Premium*  
            Mineralys Therapeutics, Inc. MLYS Director 2023-02-14 0 2024-02-12 4,850,984    Premium*  
            Janux Therapeutics, Inc. JANX Director, 10% Owner 2023-07-19 0 2023-07-19 9,165,652    Premium*  
            Lenz Therapeutics LENZ Director, 10% Owner 2024-03-21 0 2024-03-21 694,755    Premium*  
            Boundless Bio, Inc. BOLD 10% Owner 2024-04-02 0 2024-04-02 295,844    Premium*  
* Premium Members only  

Records found :    216         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-10-18 4 B $3.76 $882,844 I/I 234,799 3,009,197 1.5 -
RXST Rxsight, Inc. 10% Owner   –       –       •   2021-08-03 3 IO $0.00 $0 I/I 0 3,052,796 %
ELYM Eliem Therapeutics, Inc. Director   –       •       •   2021-08-09 3 IO $0.00 $0 I/I 0 3,083,332 -
PHAT Phathom Pharmaceuticals, ... 10% Owner   –       –       •   2021-03-11 4 S $43.75 $31,062,500 I/I (710,000) 3,115,008 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-10-19 4 B $3.89 $488,659 I/I 125,726 3,134,923 1.5 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-10-20 4 B $3.95 $44,801 I/I 11,342 3,146,265 1.5 -
ETNB 89bio, Inc. Director   –       •       •   2019-11-13 4 A $0.00 $0 I/I 1,661,214 3,161,214 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-10-21 4 B $3.92 $188,552 I/I 48,100 3,194,365 1.5 -
BDTX Black Diamond Therapeutic... Director   –       •      –    2023-07-05 4 B $5.00 $4,679,250 I/I 935,850 3,213,828 2.1 %
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-10-24 4 B $3.91 $103,459 I/I 26,460 3,220,825 1.5 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-12-08 4 B $3.75 $39,750 I/I 10,600 3,231,425 1.5 -
SCPH Scpharmaceuticals Inc. 10% Owner   –       –       •   2020-02-14 4 B $8.20 $2,230,343 I/I 271,993 3,247,005 1.5 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2022-12-09 4 B $3.93 $75,845 I/I 19,299 3,250,724 1.5 -
CRDF Cardiff Oncology Inc 10% Owner   –       –       •   2020-09-30 3 IO $0.00 $0 I/I 0 3,290,000 -
STSA Satsuma Pharmaceuticals, ... Director   –       •       •   2019-09-17 4 A $0.00 $0 I/I 3,348,525 3,348,525 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-07-08 4 B $27.50 $7,562,500 I/I 275,000 3,436,214 1.5 %
SCPH Scpharmaceuticals Inc. 10% Owner   –       –       •   2020-02-14 4/A B $8.20 $2,230,343 I/I 271,993 3,518,998 1.5 -
PHAT Phathom Pharmaceuticals, ... 10% Owner   –       –       •   2019-10-25 3 IO $0.00 $0 I/I 0 3,646,646 -
PHAT Phathom Pharmaceuticals, ... 10% Owner   –       –       •   2020-02-06 3/A IO $0.00 $0 I/I 0 3,646,808 -
PHAT Phathom Pharmaceuticals, ... 10% Owner   –       –       •   2020-03-27 4 B $24.60 $738,000 I/I 30,000 3,676,808 1.5 -
ANTX An2 Therapeutics Ord Shs 10% Owner   –       –       •   2022-06-13 4 B $7.90 $158,000 I/I 20,000 3,686,663 1.5 %
PHAT Phathom Pharmaceuticals, ... 10% Owner   –       –       •   2020-03-31 4 B $24.55 $751,264 I/I 30,600 3,707,408 1.5 -
ANTX An2 Therapeutics Ord Shs 10% Owner   –       –       •   2022-06-14 4 B $7.97 $489,402 I/I 61,424 3,748,087 1.5 %
ANTX An2 Therapeutics Ord Shs 10% Owner   –       –       •   2022-06-21 4 B $7.99 $2,413 I/I 302 3,748,389 1.42 %
ANTX An2 Therapeutics Ord Shs 10% Owner   –       –       •   2022-07-26 4 B $7.71 $115,172 I/I 14,938 3,763,327 1.5 %
  216  Records found
  1   2   3   4  5   6   7   8   9      
  Page 4 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us